CARE Program for Postpartum Mental Health (PMAD-CARE Trial)

N/A

Recruiting

Led By Amanda Zayde, Psy.D.

Research Sponsored by Montefiore Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the tfi-19 will be administered after participants complete session 1 of group (approximately 0-2 weeks after baseline measurement) and again at post-treatment (after completion of session 12, approximately 15 weeks after baseline measurement).

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a group therapy program called CARE for parents with postpartum depression or anxiety. The program helps parents understand their own and their baby's thoughts and feelings to improve mental health and reduce stress. The study targets parents with infants aged 3 to 12 months who are receiving care at Montefiore Medical Center.

Who is the study for?

This trial is for postpartum parents who have given birth within the last 3-12 months, are English-speaking, and are currently receiving care at Montefiore Medical Center. It's aimed at those experiencing moderate to high levels of depression or anxiety after childbirth. Parents already in a CARE group or another parenting program, with severe mental health issues needing intense treatment, or current psychosis/mania can't participate.

What is being tested?

The study tests the Connecting and Reflecting Experience (CARE) Program—a group therapy designed to improve mental health, reduce parenting stress, and strengthen parent-infant relationships among postpartum parents with mood/anxiety disorders. Participants will attend 12 sessions and complete surveys to assess the program's impact on their well-being.

What are the potential side effects?

As this is a psychological intervention rather than a medical one, traditional side effects like those seen with medications aren't expected. However, discussing sensitive topics during therapy could potentially cause emotional discomfort.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the tfi-19 will be administered after participants complete session 1 of group (approximately 0-2 weeks after baseline measurement) and again at post-treatment (after completion of session 12, approximately 15 weeks after baseline measurement).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the tfi-19 will be administered after participants complete session 1 of group (approximately 0-2 weeks after baseline measurement) and again at post-treatment (after completion of session 12, approximately 15 weeks after baseline measurement).

This trial's timeline: 3 weeks for screening, Varies for treatment, and the tfi-19 will be administered after participants complete session 1 of group (approximately 0-2 weeks after baseline measurement) and again at post-treatment (after completion of session 12, approximately 15 weeks after baseline measurement). for reporting.